Preserving identity or promoting safety? The issue of Mercury in Siddha Medicine: a brake on the crossing of frontiers by Sébastia, Brigitte
Brigitte Sébastia*
Preserving Identity or Promoting Safety?
The Issue of Mercury in Siddha Medicine:
A Brake on the Crossing of Frontiers
DOI 10.1515/asia-2015-1043
Abstract: Since the publication of a sanitary alert on the toxicity of ayurvedic
products by Robert B. Saper and colleagues in the Journal of the American
Medical Association (JAMA) in 2004, the image of ayurveda as a safe alternative
or complement to biomedicine has sharply deteriorated in North America and
Europe. In reaction, some western countries have forbidden the import of the
herbal products denounced by Saper and colleagues’ warning, and the
Government of India has taken measures to implement its rules on their produc-
tion to ensure the full safety of the products intended for both export and
national markets. This seriously hinders the export of siddha remedies as they
may contain metals, mercury being one of their iconic ingredients. It has also
created problems for their production, as the companies that manufacture
siddha products are, in general, less developed than their ayurvedic counter-
parts. I will discuss this event and its impact on regulations in Europe, the
United States and Canada and in India in the first part of this chapter. In the
second part, I will explore the ideological and spiritual position of siddha
medicine and its relation to iatrochemistry in order to comprehend why it has
the reputation of a metal- and mineral-based medicine, and in particular, a
mercury-based medicine. The third part, based on research conducted in 2007
on private and governmental siddha firms and the traditional siddha milieu
throughout Tamil Nadu, will focus on the production of siddha medicaments
and their marketing, as well as on the diverse means by which they cross
frontiers for consumption abroad.
Traditional medicines have been repeatedly criticized in scientific literature1 for
causing poisoning due to high levels of heavy metals such as lead, arsenic and
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mercury. Although all traditional medicines are under scrutiny, ayurvedic pro-
ducts are among the most frequently mentioned due to their great popularity in
the West (i.e. Europe, the United States, Canada), their consumption by large
diasporic Indian communities, and their easy accessibility on the Internet. Sold
as herbal products, dietary supplements or nutraceuticals, ayurvedic remedies
are not considered dangerous by consumers. On the one hand, the term “herbal”
suggests nature, well-being, and safety, representations strongly supported by
the abundant popular literature on ayurveda. On the other hand, the public is
rarely informed that herbal or ayurvedic medicines may contain heavy metals
(including mercury), as the components listed on labels are either not decipher-
able by lay people or poorly presented on the internet.
In 2008, an extensive survey conducted by Robert B. Saper and his collea-
gues on the high levels of heavy metals in ayurvedic herbal medicine products
(HMPs) manufactured in India and the US and sold on the US market and on the
internet in 2005 was published in the Journal of the American Medical
Association (JAMA). It concluded that of one hundred and ninety-three products,
20.7% presented a high level of heavy metals with a prevalence higher in
products from US (21.7%) than those from India (19.5%); the level of heavy
metals was also higher in metal-based medicines (rasaśāstra) (40.6%) than in
herbal-based ones (non-rasaśāstra) (17.1%), concentrations of lead and mercury
being respectively 11.5 μg/g versus 7.0 μg/g and 20,800 μg/g versus 34.5 μg/g.2
This survey followed a primary study by Saper and colleagues conducted on
ayurvedic HMPs sold on the US market which had revealed that of seventy
ayurvedic medicines, fourteen contained a higher level of heavy metals (mer-
cury, lead, arsenic, cadmium) than the permitted limit. The researchers carried
out these surveys with regard to the number of intoxications reported in medical
literature: “Since 1978, at least 55 cases of intoxication by heavy metal asso-
ciated with ayurvedic HMPs in adults and children have been reported in the
United States and abroad”.3 However, compared to the high incidence of heavy
metals detected by Saper and his colleagues, it is surprising that the number of
reported intoxication cases was so small, around 2 cases per year. One reason
may be that not all cases were reported in medical literature or were not
identified as caused by herbal medicines. But another reason may be the
2 According to the American National Standard Institute (ANSI 173) mentioned by Robert B.
Saper et al. (2008: 918): “the dietary supplements should not contain undeclared metals that
would cause intakes greater than 20 μg/day of mercury, 20 μg/day of lead, and 10 μg/day of
arsenic.” Concerning mercury, WHO (2007) estimates that its tolerable intake per day is 2 μg/kg
body weight.
3 Saper et al. 2004: 2868.
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limitation of the 2004 and 2008 studies by Saper et al., which did not test or
even discuss the bioavailability of the heavy metals detected in the examined
herbal medicines. However, neglecting this fundamental criterion for measuring
the toxicity of products, they concluded:
The presence of heavy metals in Ayurvedic HMPs and the numerous reports of associated
toxicity may have important public health, clinical, and policy implications in the United
States and abroad. Although the prevalence of heavy metal – containing Ayurvedic HMP
use is unknown, the number of individuals at potential risk is substantial. Recent analysis
of the US National Health Interview Survey 2002 Alternative Medicine Supplement esti-
mates 750000 adults consulted an Ayurvedic practitioner in the past.4
In other words, the authors adopted a zero-risk stance in regard to any ayurvedic
HMP and encouraged their non-consumption. They also advised that the Dietary
Supplement Health Education Act 1994 (DSHEA) be reformed. However, given
that some HMPs should not be commercialised as dietary supplements but as
medicines, which would therefore be regulated by the Food and Drug Act (FDA)
that controls the quality and safety of products before and during their commer-
cialisation, the American Herbal Products Association (AHPA) opposed the
reform of the DSHEA: “No change in the law is required, though manufacturers,
importers and retailers need to assure that the products they manufacture, import
and sell are free of adulteration.”5 The DSHEA, in contrast to the FDA, defines the
manufacturers as responsible for the quality of their dietary supplements.
Eight years after his initial survey, Saper participated in research that aimed
to assess the bioavailability of lead and arsenic in the ayurvedic HMPs tested
positive in the first studies.6 The research revealed that only one tier of the
sample, i.e. 7% of ayurvedic HMPs presented a soluble form of lead and arsenic,
and was possibly toxic. Unfortunately, they did not conduct research on the
bioavailability of various forms of mercury. Some articles, however, have explored
this subject.7 They conclude that mercuric sulphide (cinnabar or iliṅkam), the
most commonly used mercurial complex in siddha medicine, is the most insoluble
mercuric compound and thus less toxic than mercuric chloride (calomel or
pūram), mercuric perchloride (vīram), or liquid mercury (iracam), but that the
long-term ingestion of drugs made from it may cause renal failure by
4 Saper et al. 2004: 2872. The survey mentioned is by Barnes P.M. et al. (2004): Complementary
and Alternative Medicine Use Among Adults: United States, 2002. Rockville, Md: Advance Data
From Vital and Health Statistics, US Dept of Health and Human Services.
5 http://www.nutraingredients-usa.com/Research/Ayurvedic-herbals-heavy-in-metals-or-not
(retrieved 11.06.2014)
6 Koch et al. 2011.
7 Liu et al. 2008; Kumar 2006; Sushant 2012.
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accumulation. These studies, which call for increasing research on the bioavail-
ability of mercury and other heavy metals, seem to moderate the initial statements
concerning the risk of intoxication intrinsic to HMPs. But the newer research has
had less of an impact than the first articles by Saper and colleagues, which
continue to be referred to in discussions on heavy metals in herbal medicines.
The bioavailability of heavy metals in the organism remains little explored.
The sanitary alert launched by Saper et al. rapidly spread. On March 3, 2005,
the journal of Health Canada published a “report of concern” stating that:
Health Canada has reviewed the findings of the JAMA study and is currently determining
the availability in Canada of the products named in the study. A Customs Alert to the
Canada Border Services Agency has been issued to monitor importation of these products.
Further action will be taken if any of the remaining products are confirmed to be sold in
Canada, and if laboratory testing determines that heavy metal levels exceed Canadian
exposure limits.8
On July 14, a second article in the same journal claimed that some ayurvedic
products with high levels of mercury and lead had been detected in Singapore. It
advised customers to be cautious when purchasing health products from outside
Canada or over the Internet and to buy only authorised health products bearing
an eight-digit Drug Identification Number (DIN), or a Natural Product Number
(NPN).9 Health Canada took measures to ban the marketing of products incri-
minated by Saper and colleagues and by other studies, and alerted the popula-
tion to the dangers of consuming them.10 Other governmental agencies, such as
the Medicines and Health Products Regulatory Agency, U.K (MHPRA) August 19,
2005 and Swissmedic in a press statement on August 17, 2006 followed suit,
issuing statements in August 2005 and August 2006, respectively.11
8 http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/13387a-eng.php
(retrieved 11.06.2014)
9 http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2006/13117a-eng.php#!
prettyPhoto (retrieved 11.06.2014)
10 The products mentioned by Saper et al. are: Karela, Bala Guti, Bala Sogathi, Bal Chamcha,
Balguti Kesaria, Gesari, Safi, Navratna Rasa, Swarna Mahayograj Guggulu with gold,
Mahayograj Guggulu with silver and Makardhwaj, Mahalakshmi Vilas Ras with gold; Maha
Sudarshan churna, and Shilajit; not all of these are prepared with metals. The journal of Health
Canada added four contaminated products from Singapore mentioned in the study: Annai
Aravindh Herbals Rheuma-7 capsules (siddha), Himalaya Diabecon Tablets, Laurel’s Diabecs
Capsules and Goodcare Diabet Guard Granules.
11 See the MHPRA statement of August 19, 2005: http://www.nutraingredients.com/Regulation/
Ayurvedic-heavy-metal-warning-hits-UK (retrieved 11.06.2014) and the Swissmedic press statement
of August 17, 2006: www.swissmedic.ch/Archiv/Asiatische_Arzneimittel_F.pdf (retrieved 08.07.
2007).
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The publicity about adverse drug reactions to ayurvedic medicines forced the
Indian government to react as medicinal plants and ayurvedic products represent
an important export that the government cannot neglect. According to the
Ministry of Commerce and Industry, the export of medicinal herbs and of
AYUSH medicines (ayurveda, yoga and naturopathy, unani, siddha, homeopathy)
in 2012–2013 represented 232.14 and 163.44 millions USD, respectively.12 On
September 24, 2005, an article in The Hindu Business Line said: “Following the
warnings issued by health regulators in the UK and Canada, the Health Ministry is
putting in place basic parameters for companies manufacturing ayurvedic and
unani products”.13 The Health Ministry announced that: “The manufacturing
facilities would have to be GMP (Good Manufacturing Practices) compliant,
though this has been notified in the Drugs and Cosmetics Act,” and that
“Companies will have to list out all the inputs, including the metals present.”
On 13 October 2005, the department of AYUSH made Schedule T compulsory,
which amended the Drugs and Cosmetics Act 1940 and Rules 1945 on June 23,
2000.14 The manufacturers have to obtain the GMP certificate in order to commer-
cialise their products. The certificate takes into account several laws that regulate
the protocols of fabrication, equipment, installations and quality controls of
pharmaceutical, veterinary and cosmetic products, as well as of medical equip-
ment and food. It guarantees the respect of norms with regard to the hygiene of
staff, places of fabrication and their management, stages of fabrication, packa-
ging, labelling and storage, and quality control from raw materials to finished
products. On October 14, 2005, the Drugs and Cosmetics Act 1940 and Rules 1945
were again amended. From January 1, 2006 they stated:
The partially modified order requires all exporters of purely Herbal Ayurvedic, Siddha &
Unani medicines to either display on the container of such medicines to be exported, the
words Heavy Metals within permissible limit or submit to the authorities batch wise testing
report (in respect of every such medicine to be exported) from any approved laboratory
stating that the medicine contains. It will be the responsibility of the representative of DCG
(I) deployed at the Airport/port of shipment to examine and ensure that all exporters of
purely Herbal Ayurvedic, Siddha & Unani medicines comply with this order.15
12 http://pib.nic.in/newsite/erelease.aspx?relid¼ 101153 (December 9, 2013, retrieved 11.06.2014).
The website presents the values of herbs and AYUSH products in the years 2010–2011, 2011–2012
and 2012–2013. It is worth pointing out that the values of AYUSH products between 2010–2011
and 2012–2013 have increased by only 4% while those of herbs have dramatically increased by
63.86%.
13 Subramanian 2005.
14 See Schedule T in Arora 2007: 457–466)
15 Pharmexil 2005. The amended texts may be consulted at: http://www.choksilab.com/
AyurvedicMeds_HeavyMetals_Orders_%20D&C_%20Act.pdf (retrieved 18.06.2014)
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The medicaments sold in India that incorporate ingredients listed in Schedule E
(1) of the Drugs and Cosmetic Rules 194516 have to be labelled “Caution: to be
taken under medical supervision.” This notification is important in India
because self-medication is very common, whatever the type of medicine. Self-
medication is also a cause of intoxication by herbal medicines and its variants in
developed countries as they are easily accessible over the counter. The imple-
mentation of the compulsory rules, with the risk of losing the license, was fixed
for 1st July 2006, in order to allow manufacturers to clear their stock and
reorganise their firms to fit in with the rules.17 The companies with the GMP
certificate are large and well represented in India as well as abroad. The
certificate does not, however, prevent them from selling products with high
levels of heavy metals as shown by Vikas Gupta and colleagues.18 The rules of
the GMP require such high expenditure that many smaller manufacturers do not
have the means to respect them. This weakens the sector of siddha manufactur-
ing as this medical system is much less widely spread than ayurveda in India
and virtually unknown abroad.
1 Siddha medicine: a combination of esotericism
and alchemy
Articles on heavy metals in Indian medicines always focus on ayurvedic (or what
they interpret as ayurvedic) products. However, the products from the other
traditional Indian medicinal systems should also be scrutinized, as they are
heavily consumed by South Asians: unani drugs by Muslim communities in
India, Pakistan and Bangladesh, and siddha drugs by Tamils in India and Sri
Lanka, and also, by South Asian migrants. Indeed, one ayurvedic HMP cited by
16 See the list in Arora 2007: 267–269. The lists of poisonous substances are mentioned in
Schedule T for ayurvedic, siddha and unani systems. Surprisingly, while the lists of ayurvedic
and unani systems are composed of drugs of vegetable, animal and mineral ingredients, that of
the siddha system refers only to vegetable ones and poisons such as arsenic, mercury and their
salts and other metallic salts specified for the ayurvedic system, are not mentioned for siddha
(Arora 2007). It is worth noting that a law on poisons has existed in India since January 22,
1904. It was revised in 1919 under the name of Poisons Act 1919. However, except for white
arsenic which was especially focused on in the 1904 regulation, the act of 1919 does not
mention any poisons in medicines (see Poisons Act 1919 in Arora 2007: 780–784 and Poisons
Act 1904 at: http://lawmin.nic.in/legislative/textofcentralacts/1904.pdf).
17 Ayurveda and Health Tourism, March 13, 2008. URL: http://ayurvedamagazine.org/ayush-to-
enforce-label-rules-from-july-2006 (retrieved 20.03.2015).
18 Gupta at al. 2013.
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Saper et al. is a unani drug and one mentioned by the journal of Health Canada
is from a siddha firm. However, ayurvedic products are more heavily represented
on the global market than siddha or unani ones, due to the more established
reputation of ayurveda, the extent of its pharmaceutical sector in India and
abroad, the significant development of medical tourism in India and spas
abroad, and the more copious offer of its products on the Internet.
Ayurveda, siddha and unani medicines are defined as Indian systems of
medicine and financially supported by the Government of India. Together with
two other medical systems, yoga/naturopathy and homeopathy, they have been
managed by the department of AYUSH of the Ministry of Health and Family
Welfare since 2003; Tibetan medicine (sowa-rigpa) was added to the department
in September 2009. In 2014, the AYUSH department was made a ministry in its
own right. While unani is available in towns where there are substantial Muslim
communities, siddha medicine, the traditional medical system of Tamil Nadu, is
commonly assimilated to ayurveda. The subsumption of siddha to ayurveda
goes back to the beginning of the twentieth century when the institutionalisation
of Indian medicines was debated in India.19 In the reports of committees ruling
on the creation of the school of Indian medicine at Madras for ayurveda, siddha
and unani systems, siddha medicine is seldom mentioned. The report of Khan
Bahadur Muhammad Usman explains: “It is well known that the Siddha and the
Ayurveda have very many things in common including the Tridhatu Physiology
and the Tridosha Pathology.”20
Siddha and ayurvedic medicines share many theoretical concepts.21 Siddha
medicine possesses, however, some distinctive diagnostic methods: elaborated
readings of pulse, and of urine using one drop of sesame oil for quantifying the
imbalance of the three doṣakkaḷ and determining the disease.22 But its determin-
ing difference from ayurveda is its anchorage in Tamil culture and in esoteric
alchemy and tantrism. In the Usman report, siddha medicine is called Tamil
medicine or Tamil ayurveda. The term siddha seems to have emerged at the
beginning of the twentieth century under the influence of the Dravidian move-
ment, an anti-brahmanical movement supported by a strong consciousness of
19 Hausman 1996; Sébastia 2010.
20 Usman 1923: 1.
21 These include, for example, the concepts of pañcabūtaṅkaḷ (five basic elements), doṣakkaḷ
(vātam-pittam-kapam: the three humours, “wind” – “bile” – “phlegm”), tatukkaḷ (seven body
constituents) and kuṇaṅkaḷ (the three properties sattva-rajas-tamas), some diagnostic and
therapeutic techniques and materia medica. Scharfe 1999; Weiss 2008, 2009.
22 Kutumbiah 1973. Urine reading is currently practised in siddha colleges but I have never
seen it practised in the traditional milieu. By contrast, pulse reading, which is an essential
diagnostic tool in traditional healing, is negligently practised and taught in colleges.
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Tamil identity.23 While ayurvedic literature is predominantly written in Sanskrit
and is associated with brahmanical learning, the siddha medical corpus was
written in Tamil and today, training (even in siddha colleges) and practice are in
Tamil. There are also differences in each tradition’s presentation of its origins:
The transmission of ayurveda is associated with brahmanical gods who passed
their knowledge to demi-gods, saints, and doctors, while that of siddha is
associated with a category of yogis called cittarkaḷ (accomplished, perfect, the
Tamil equivalent to the Sanskrit word siddha). These cittarkaḷ are thought to
have acquired great powers (karmamurai) through asceticism which gave them
the ability to transcend the materiality of the sensory world. They are considered
the authors of texts on medicine and related subjects: botany, pharmacopeia,
diagnosis, treatment, yoga, astrology, spirituality, magic and, especially,
alchemy and iatrochemistry, the knowledge of which they developed through
extreme ascetic practice. According to the Tamil tradition, there are eighteen
cittarkaḷ, but their number reaches more than ninety if the various lists pre-
sented in siddha literature24 and in the inventory of manuscripts25 are taken into
account. This increase in the number of cittarkaḷ results from the term cittar,
which signifies “who has acquired omniscient wisdom” and has been attributed
to individuals who led an outstanding, spiritually-oriented life. Historians have
underlined the fact that many siddha texts were written under the name of
famous cittarkaḷ such as Agattiyar,26 Tēraiyar, Irāmatāvar or Pōkar,27 blurring
the chronology and authorship of siddha texts and making it difficult to trace
the evolution of siddha knowledge and philosophy. Attempts by K. Meenakshi
(2001) and, especially by R. Venkatraman (1990), have sought to establish the
chronology of some cittarkaḷ and to explore their ideological position with
regard to politics, religion and spirituality. These authors as well as other
historians28 have asserted that the cittarkaḷ were anti-brahmanical, anti-ortho-
dox, anti-ritualistic, anti-conformist and firmly opposed to the caste system
imposed by brahmanical culture. The philosophical orientation of the Tamil
23 Sébastia 2012; Weiss 2009.
24 See Ganapathy 1993: 24–26; Shanmugavelan 1963: 16–17; Venkatraman 1990: appendix 2,
198–208; White 2004: 87.
25 See Madhavan 1984: 20–26; Palanichamy 1973: 3.2: 74–75 and 3.3: 132–134; Samuel 1998:
xvi.
26 Agattiyar (Agastiyar in Sanskrit) is considered as the founder of Tamil medicine. In several
occurrences in the poem Cilappatikāram (third century B.C.E.), he is presented as the great sage
of the Potiyai hills (in the Pandya kingdom). There is no mention of his supposed great
knowledge of grammar or medical subjects (Parthasarathy 1993).
27 Kutumbiah 1973: 21; Venkatraman 1990: 49–75.
28 Ganapathy 1993; Zvelebil 1973.
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cittarkaḷ is tantrism, a heterodox movement based on non-dualism and the
principle of the unity of Śiva-Śakti.29 Representations of Śiva-Śakti are found
in the homes of some traditional siddha practitioners, in the room where
medicines are prepared or in domestic shrines where medicines are placed
before being given to the patients.
Today, Siddha medicine is more strongly associated with alchemical pro-
cesses and with the use of mercury in particular than ayurveda. We already find
this association asserted in the Usman report of 1923:
There is clear evidence that this [iatrochemistry] was pursued with special interest by the
Siddhas; it is claimed that their achievement in chemistry was greater, and dated from a
much earlier period than that indicated by Sir P.C. Ray, in his monumental work on The
History of Hindu Chemistry (…) However this may be, there is no denying the fact that,
even in modern days, the practitioners of Siddha system known the secret of using
mercury, arsenic, and other powerful “poisons” in such forms as eliminate, so to speak;
their “poisonous” properties but as the same time concentrate their beneficial ones.30
However, a comparative study of these two medical systems does not confirm this
specific association: The mineral and metallic components are common to the
ayurvedic and siddha materia medica, and ayurvedic literature heavily borrows
from rasaśāstra (the Sanskritic tradition of alchemy and iatrochemistry) treatises.
However, a detailed comparison of iatrochemical elements in siddha and ayurve-
dic literature is at present hampered by the paucity of available editions and
translations of siddha texts. Only few siddha manuscripts have been examined
so far. Our very limited knowledge of (and access to) siddha literature makes it
difficult to discriminate the alchemical elements which belong to the siddha
tradition from those which belong to ayurveda, and more widely, to Chinese,
Middle East and western traditions.31 Asian alchemical traditions have focused
specifically on mercury, perhaps to a higher degree than the Arabic and European
29 The Śiva-Śakti principle is the union of Śiva with Śakti which, through kuṇḍalinī yoga, allows
for attaining the state where “all consciousness of duality and fear of falling again into the bond
of samsara are removed forever” (Ganapathy 1993: 87). This yoga is performed to develop eight
supernatural powers (karmamurai; siddhi): aṇimā (power of becoming very small), laghimā (of
becoming very light), prāpti (of obtaining everything), prākāmya (of having irresistible will),
mahimā (of increasing one’s size), iśitva (of becoming superior, great), vaśitva (of bringing others
under one’s control) and kāmāvasāyitā (of suppressing passion) (Banerji 1992: 628). The names of
the supernatural powers are in Sanskrit, even in the Tamil siddha tradition.
30 Usman 1923: 87.
31 David Gordon White (2004: 2) argues that Indian tantrism was “influenced by cultural interac-
tions with China, Tibet, Central Asia, Persia and Europe, interactions which had the Silk Road and
medieval maritime routes and ports as their venue”. Books I consulted for the comparison are: for
ayurveda, Vaidya Bhagwan Dash (2003), Jean Filliozat (1979), S. Mahdihassan (2002), G. Jan
Meulenbeld (Volume II A and B, 2000), Rasacharya Bhudeb Mookerji (2006), Himasagara P.
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alchemical traditions. Cittar alchemists developed numerous elaborate processes
for extracting mercury from cinnabar (see Figures 1–6), these products becoming
then either medicaments or miraculous substances for increasing the eight kinds of
supernatural power (aṭṭa karmamurai). Some of these processes are also described
in ayurvedic literature.32 Venkatraman points out that nothing in Caṅkam litera-
ture33 “makes reference to metallic or mercurial medicine or salts or mineral
poisons.”34 He asserts, from evidence from the Cola period (9th–13th), that the
type of medicine practised in this region was simply ayurveda; metal and metallic
substances having been borrowed from Buddhist tantrists, among them Nagārjuna
(tenth century C.E.).35 The fact that a large part of terminology of Tamil alchemy
and medicine is predominantly from Sanskrit may confirm this.36
Figure 1: Grinding
cinnabar and curcuma.
Chandra Murthy (2008), Prafulla Chandra Ray (1925), P.K. Sanyal (1964); for Occident and Middle
East, Frank Greiner (1998), Serge Hutin (1995); for China, Kristofer Schipper (1997), Frédérique
Obringer (1997).
32 Mookerji 2006: v. 1, 49–51; Murthy 2008: 174–175.
33 Caṅkam literature refers to a collection of Tamils poems whose the date is uncertain (second
century B.C.E. to 5th C.E.). The poems describe the life of Tamils before the brahmanisation of
South India (Tieken 2003).
34 Venkatraman 1990: 116.
35 Ray 1925; Kutumbiah 1973; and Roy/Subbarayappa 1976 wrongly considered Nāgarjuna the
author of theRasaratnākara. See David GordonWhite for the lists of alchemical works, their authors
and period of writing (2004: 78 et sq.). According to him, the Rasaratnākara was written by
Nityanātha Siddha in thirteenth to fourteenth century and not by Nagārjuna. This is also supported
by Jean Filliozat (1979), G. Jan Meulenbeld (2000 Volume II A), and Dominik Wujastyk (1983).
36 It is worth mentioning, however, that alchemy in siddha medicine is called vātam while
iracam is restricted to mercury (Tamil lexicon).
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Figure 3: Putting the
rolled up cloth into a
pot scrubbed with
a plant juice.
Figure 2: Laying the
powdered mixture on a
cloth.
Figure 4: Putting fire to
the cloth with camphor.
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Figure 5: Closing the
pot for the process
of sublimation.
Figures 1–6: Extraction of mercury from cinnabar (iliṅkam): Photos of a traditional siddha
practitioner involved in yoga and siddha medicine preparation courses ©Christian Sébastia.
Figure 6: Collection of mercury drops
after the process of sublimation.
944 Brigitte Sébastia
A comparison of the siddha and ayurvedic formularies37 shows that more
siddha preparations are based on mercury (32.3%) than ayurvedic ones (26.6%),
cinnabar or iliṅkam being the most used component from which mercury is
extracted.38 While the formulary of ayurvedic medicines has a large category of
medicines mostly based on mercury called rasauṣadhi (mercury-medicinal herbs),
the formulary of siddha medicines lists several specific groups of metal/mineral-
based preparations that quite often include mercury and mercurial components.
These groups are: cuṇṇam39; kalaṅku40; kaṭṭu41; karuppu42; pantaṅkam,43
kulampu.44 Moreover, the siddha tradition possesses four specific substances
which do not exist in ayurvedic alchemy and whose formulations are unknown:
37 These statistics have been calculated from the siddha and ayurveda formularies of IMPCOPS
(Indian Medical Practitioners’ Cooperative Pharmacy and Store) which are compilations of
formulas current in these two medical systems. See Formulatory of Siddha Medicines (2000)
and Vaidya Yoga Ratnavali (Formulatory of Ayurvedic Medicines) (2000). The analysis of the
siddha formulary used in the Siddha Government Medical College of Palayamkottai shows that
of 245 formulas, 75 contain a form of mercury often associated with arsenic or sulphur (30.6%),
8 are based on arsenic (3.3%), 16 on iron, zinc or lead (6.5%) and 56 on one or several minerals
(22.9%), the 90 other formulas being composed of plants (37.7%).
38 A few metals and minerals have a Tamil name in Siddha medicine that is different from their
Sanskrit name used in ayurveda. Let us mention: vīram (mercuric chloride); vellai pāṣāṇam
(arsenic trioxide); annapēti (ferrous sulphate); turucu (copper sulphate); ayam (iron); nākam
(zinc); karuvaṅkam (lead); velvankam (tin); taṅkam (gold); veḷḷi (silver); paṭikāram (alum);
veṅkāram (borax); vetiyuppu (saltpetre); cōrruppu (sea salt); intuppu (rock salt). This list is
derived from a comparison of the formularies of ayurveda of IMPCOPS (Vaidya Yoga
Ratnavali 2000) and of siddha medicine of IMPCOPS (Formulatory of Siddha Medicines 2000)
and of the Government of India (The Siddha Formulary of India 1992; The Siddha Pharmacopoeia
of India 2008). However, in siddha manuscripts many metal or mineral ingredients are specified
in metaphorical terminology that only specialists are able to decipher, iliṅkam, a reference to
the phallic representation of Śiva, being the best example.
39 White powder obtained from an intensely calcined form of mercury or mineral ground with
plant juices or extracts which turn red with turmeric.
40 Mercury or mercurial or arsenical salts moderately heated and melted in plant juice, and
then intensely heated for forming a solid mass, and lastly highly calcined.
41 Kaṭṭu is defined as a poisonous compound like cinnabar and arsenic hardened under the
long-term action of plant juices absorbed by the compounds while they are kept over fire.
According to the category of kaṭṭu, gems may be included as components.
42 Mixing of mercury and mercurial components with sulphur or arsenic intensively ground
and moderately calcined and of black colour.
43 Organic and inorganic substances, notably mercurial and arsenical salts, sublimated in a
high temperature and then finely powdered.
44 Medicine prepared by grinding diverse plants with mercury or cinnabar and camphor until
obtaining a waxy consistence.
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navapāṣāṇam,45 iracamaṇi,46 kaṭṭu47 (Figure 7), and muppū.48 These substances,
half alchemical products, half medicines, are considered highly valuable by
cittamaruttuvarkaḷ, acting either as panacea, as kāyakarpam (substances for reju-
venating the body), or as catalysts for increasing the efficacy of the medicament.
Among the four substances, iracamaṇi is quite commonly prepared by
cittamaruttuvarkaḷ interested in alchemy, following processes described in
texts by cittarkaḷ and ayurvedic alchemists. These texts delineate the mixing of
mercury and sulphur, metaphorically designated as the combination of the male
and female principles and processed with plants and/or other metals.49 The high
Figure 7: Traditional
siddha practitioner’s
family’s kaṭṭukaḷ
©Christian Sébastia.
45 In Sanskrit, pāṣāṇam means “stone” and in Tamil “stone, poison, arsenic”. Arsenic is of two
categories: piravippāṣāṇam (natural) and vaippuppāṣāṇam (artificial), each category comprising
thirty-two kinds. According to the siddha practitioners, navapāṣāṇam is a material made of nine
poisons, mostly of arsenic and mercuric components triturated with plant juice. The colour of
products claimed to be navapāṣāṇam is brown.
46 Iracamaṇi means “pearl of mercury”. It is made from solidified or coagulated mercury. It is
not specific to siddha alchemy as it is found in all alchemical traditions, but iracamaṇi is
commonly presented by traditional siddha practitioners as a symbol of their profession.
47 Kaṭṭu are extremely potent stones made of metallic components including mercurial salts
that the cittamaruntuvar rubs on a mortar stone to obtain some fine particles that he mixes with
honey or milk and gives to the patient to swallow. While several practitioners showed me some
products which they had themselves produced and which they called muppū and navapāṣāṇam,
none had succeeded in making kaṭṭu. These stones are different that the kaṭṭukkaḷ of the Siddha
Formulary of India.
48 Muppū, a term of Tamil origin, is a combination of three salts, among them one, pūnīr
(water of the earth), is collected during the full moons of summer (from April to June) in certain
dry areas kept secret (See for example the Akattiyar’s texts in G. John Samuel 1998).
49 See Mookerji 2006, volume 1 and Samuel 1998.
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value attributed to such substances has favoured their mythologization so that
some cittamaruttuvarkaḷ, deeply involved in esotericism and alchemy, tirelessly
conduct experiments in order to create these magical products which will raise
them to the rank of master in siddha medicine (ācān, avarkaḷ). These particular
cittamaruttuvarkaḷ follow the tradition of some famous cittarkaḷ such as the
tāntric-alchemist Iramatēvar50 or Pōkar. The latter is attributed with the creation
of a statue of Murukan made of navapāṣāṇam at Palani.51 Both of these alche-
mists are regarded as having been proficient in the transformation of mercury.
Rattinammal, a ninety-year-old traditional practitioner from Madurai I inter-
viewed in 2007, for example, explained to me that, when she was psychologi-
cally disturbed after her husband’s death, she decided to test her medical
capacity by making iracamaṇi (Figure 8). She consulted several books of
Pōkar, and after several attempts, she succeeded. She fixed her iracamaṇi to
her silver finger ring. But, unlike Iramatevar who would suck the iracamaṇi to
increase his alchemical knowledge or to attain camāti through the acquisition of
the eight supernatural powers (karmamuraikkaḷ), Rattinammal uses hers for the
benefit of her patients. To those with severe diseases, she gives some drops of
milk in which she has rubbed her iracamaṇi. She has also produced a muppu for
Figure 8: Rattinammal’s iracamaṇi ©Christian Sébastia.
50 Kanchana Natarajan (2004) has devoted an extensive study to Iramatēvar.
51 The statue is known as Taṇṭayutapāṇi and is supposed to have medicinal value. The
tradition tells us that devotees used to scratch the statue to get some material that they
swallowed. To protect it from more degradation, it was removed to a secret place. According
to Venkatraman (1990), the statue’s story, for which he has found no evidence, is partly
responsible for the reputation of this Murukan site.
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replacing that of her mother. She is no longer able to prepare one because her
great age does not allow her to search for punīr.52 In contrast with iracamaṇi, the
other substances are more difficult to produce because their recipes are untrace-
able or expressed in an obscure metaphorical language. For example, differing
lists of ingredients circulate for the production of navapāṣāṇam.53 Nevertheless,
some practitioners such as P.M. Selvarasu, manager of the 250 year old
Kollimalai Siddhar Siddha Ashramam, claim to be able to produce it.
Selvarasu sells Śiva iliṅkam and pills made of navapāṣāṇam and of iracamaṇi
at this ashram or during his monthly medical camps throughout Tamil Nadu.
Devotees and patients buy these as amulets or protection (Figure 9). This class of
siddha practitioners contributes to the reputation of siddha as metal and
mineral-based medicine in opposition to ayurveda as herb-based. However,
despite the great knowledge and high skills of some practitioners, the future
of their medicine is jeopardized by the increasing criticsm of the perceived lack
of safety of traditional medicines.
Figure 9: Navapāṣāṇam, iliṅkam, iracaliṅkam and iracamaṇi sold by P.M. Selvarasu ©Christian
Sébastia.
52 Sébastia (2015).
53 Lists of ingredients from websites on Palani and in some siddha books are: 1 – vīram
(mercuric chloride or corrosive sublimate), 2 – raca karpūram or pūram (calomel or mercurous
chloride), 3 – rasam (mercury), 4 – cātiliṅkam (a sort of arsenic), 5 – maṇōcilai (red orpiment or
arsenic disulphide), 6 – kaurippāṣāṇam (yellow orpiment or arsenic pentasulphide), 7 – vellai
pāṣāṇam (white arsenic or arsenic trioxide), 8 – kantakam (sulphur), 9 – muritarciṅki (lead
monoxide), 10 – cilācattu (gypsum).
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2 Production of medicaments legitimized
by traditional knowledge
The number of siddha firms in Tamil Nadu is not insignificant as, according to
the report of the department of AYUSH, May 1, 2011, there exist three hundred
and forty-six of them.54 They are mostly small companies with limited produc-
tion in terms of volume and variety of medicaments. Around twenty companies
produce a hundred different kinds of medicaments, possess their own shops and
commercialise their medicines on a large scale through pharmaceutical repre-
sentatives and the internet. Those that hold the ISO certificate (which ensures
international quality) and the GMP certificate export their medicines.
Ayurvedic firms are more numerous (7,699 according to AYUSH), although of
variable size, and their products are distributed all over India. Except for R.S. Pathy,
founded in 1909 at Madurai,55 factories for siddha medicines were developed only
in the 1960s. Most of them were established by traditional practitioners who,
preparing drugs for their clientele, aspired to commercialise them on a large
scale.56 Despite becoming businessmen, these practitioners have not always broken
with their medical practice and some of them divide their time between production
and the clinic. The continuation of the examination of patients, which is always free
of cost – only drugs are sold – is a way for them to fulfil their duty to the people
(cēvai) according to the ethical code recommended by the cittarkaḷ which stressed
that medical knowledge and therapeutic proficiency57 ought not be used for
54 http://www.similima.com/ayush-2011-final-report-by-planning-evaluation-cell (retrieved
15.06.2014)
55 This firm was supervised by the founder’s two grandsons. At the beginning, the factory
produced fifty kinds of medicines which were exported to Sri Lanka, Singapore and Malaysia
from the 1950s. Nowadays it produces only one, which is still exported, a medicinal oil designed
to treat headache, joint pain, etc. Umapathy, one of the grandsons, explains the situation by his
father’s lack of ambition for, and interest in, the firm. In 2007, he confided that he sought to
revive the firm by reproducing the discontinued medicines, but met with a refusal from his
father who did not want to reveal the family formulations. The children of traditional practi-
tioners do not always inherit the medical knowledge jealously kept by their relatives and these
failures of transmission are quite often the reflection or the source of familial conflicts.
56 TAMPCOL was founded by the government of Tamil Nadu, SKM has used a siddha practi-
tioner to develop his pharmaceutical company, and siddha medicine at Santhigiri Ayurveda and
Siddha Vaidyasala was inspired by the guru, founder of the ashram.
57 Therapeutic proficiency means the ability of siddha practitioners to heal through their
knowledge and expertise in pharmacopoeia, but also through the use of mantras for disorders
they deem to have magical causes. Most siddha practitioners refuse to employ mantras today,
although some of them saw their father or grandfather using the mantras to which they
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personal enrichment.58 The price of medicines typically covers the cost of produc-
tion but does not allow for much profit. Many practitioners therefore have other
sources of income from agriculture or local political positions. It is not rare for
manufacturers to organize medical camps59 during which they provide free medi-
cines, combining thus their duty to the people (cēvai) with the means of making
their medicaments known, and attracting customers from biomedicine or ayurveda.
Their medical practice is also a way to carry on the work of their ancestors from
whom they inherited the knowledge. This anchorage in the family tradition guar-
antees the authenticity of the drugs, even though they are made industrially, and
helps the manufacturers to expand their reputation (Sébastia 2015).
To promote the standardisation of Indian medicines, the government
invested in the compilation and publication of formulas and pharmacopoeia
specific to each Indian medical system with the intention of encouraging
practitioners and pharmaceutical companies to use them. For siddha medi-
cine, it has published two volumes of The Siddha Pharmacopoeia of India.
Some of its formulas have been used by the pharmacies of governmental
siddha colleges since 1956.60 IMPCOPS (Indian Medical Practitioners’
Cooperative Pharmacy and Store), a pharmaceutical cooperative formed of
ayurvedic, siddha and unani practitioners,61 also publishes formulas of med-
icinal preparations for practitioners and pharmaceutical firms. Though some
manufacturers draw on these books, they pre-eminently opt for the recipes
inherited from their ancestors or gurus (proprietary medicines) from which
they acquire their reputation, as well as for the recipes they have developed
by consulting manuscripts and texts of the cittarkaḷ. Unlike the śāstric med-
icines whose formulas may be known to all practitioners, the formulations of
the proprietary medicines are kept secret. The manufacturers and traditional
practitioners have to maintain the competition by distinguishing themselves
attributed a psychological effect. They consider the use of mantras anachronistic and incompa-
tible with the scientificity they claim for their medicine.
58 Pillai 1968: 89–95.
59 The medical camps consist of occasional events organised by the Ministry of Health and
Family Welfare or by private hospitals with the aim of treating rural populations or peri-urban
underprivileged communities for free. These camps are oriented towards specific treatments
such as cataract surgery or vaccination. Concerning siddha medicine, the camps aim to treat all
diseases or, exceptionally, epidemics such as chikungunya for which siddha medicine has
proved its efficacy.
60 Uthamaroyan 1995.
61 This cooperative was created in Madras in 1944 by Srinivasa Murti, secretary to the Usman
Committee, who was appointed by the British government to establish the School of Indian
Medicines at Madras, to which he was appointed Principal.
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from one another.62 The usage of formulations inherited from the tradition is
of such importance that manufacturers of siddha medicine who have no
siddha background seek the cooperation of a famous cittamaruttuvar (siddha
practitioner) who will produce and commercialise his own formulas. The
association with the cittamaruttuvar allows the firm to exploit his expertise
in the matter of formulations and fabrication, and to acquire renown very
rapidly and to compete with other companies, siddha as much as ayurveda.
This is the strategy chosen by SKM, a large pharmaceutical company at
Erode, whose owner built his fortune by producing and exporting powdered
egg and milk. The formulas of its products come from the cittamaruttuvar
Vetathiri Maharishi who founded the Temple of Consciousness and initiated
the siddha medical activities of SKM, and the cittamaruttuvar Muttusamy who
was employed to manage the siddha clinic of SKM.
A change of scale in the commercialisation of medicines is possible only
insofar as the practitioners possess a patent for every product and the GMP
certificate. Patents, defined by the Drugs and Cosmetics Act 1940 (section 18 (c))
and Rules 1945 (rules 151–160), are obtained from the office of Drugs Control, on
the presentation of documents listing the ingredients of the medicines, and
giving the name of the text in the case of śāstric medicines, the process of
fabrication, and the results of the quality test. In order to qualify for GMP, the
firm has to be big enough to have rooms for the storage of raw materials, for
each process of fabrication, and for packaging, in order to avoid the risk of
contamination. Due to the high cost of production and of the quality controls
demanded for each batch of medicine, few small manufacturers are able to
respect the GMP norms, and therefore either continue to trade illegally on the
open market, or limit their production to their private clients. There is no doubt
that these regulations are necessary to ensure the quality and safety of the
products, but they impede the expansion of the siddha sector. Moreover, since
the competition between practitioners and between manufacturers is based on
the efficacy of the formulas, and thus on the importance of keeping them secret,
these norms constitute a serious obstacle for proprietary medicines as it is
compulsory to list the ingredients on labels.63
62 A practitioner in the region of Kanniyakumari, whose ancestors were renowned for the
efficacy of their medicines, possesses a leaflet by his father that denounces the use of his name
by some dishonest peers. This echoes the use of the names of reputed cittarkaḷ of the past.
63 The question of maintaining secrecy has long been part of the debates on the integration of
Indian traditional medicines and their institutionalisation. I thank one of the reviewers for
attracting my attention to the fact that the British Medical Association published a book in 1909
on this subject (British Medical Association 1909) and that secrecy runs counter to the Drugs and
Magic Remedies (Objectionable Advertisements) Act 1954 and rules 1955 (texts in Arora 2007:
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3 The export of siddha medicines: mixing siddha
and ayurveda
A means to make the production of siddha medicines feasible and to develop their
marketing is to produce them conjointly with ayurvedic ones.64 This is the strategy
used by many siddha manufacturers.65 It is facilitated by the fact that the two
systems share a large part of their materia medica, preparations such as curaṇam,
centūram, parpam and formulations such as tiripala curaṇam and tirikaṭu
curaṇam.66 Admittedly, in Tamil Nadu, patients resort to siddha as well as to
ayurveda so that the associated production of medicaments is justified.67 Having
products of both systems facilitates the commercialising of drugs beyond the
555–564). This act and these rules which forbid the use of magic in medical practice may have
limited the practice of mantra and astrology which were used in the clinic for diagnosing and
treating patients (Sébastia 2012).
64 Some siddha manufacturers, such as Aravindh Herbal Labs, also produce homeopathic
remedies. Regarding medical practice, homeopathy may be used conjointly with siddha and
ayurvedic medicines. This is facilitated by the fact that homeopathic degrees are easily obtained
by correspondence courses. Such graduates may open a hospital or a clinic in which only
siddha is practised (Sébastia 2010, 2012).
65 The most important companies (in chronological order of foundation) are: MSS Asan Export/
Zigma Herbal Remedies (1940, Nagerkovil); IMPCOPS (1944, Chennai); VKS Raja Sidhaa
Marundagam (1961, Tirumangalam); Solaimalai Indian Herbals Drugs (1965, Paramakudi);
TAMPCOL (1983, Chennai); Santhigiri Ayurveda and Siddha Vaidyasala (1988, Koliyacode); Dr
JRK’s Siddha Research and Pharmaceuticals (1990, Chennai); Aravindh Herbal Labs (1992,
Rajapalayam); SKM Siddha and Ayurveda (1993, Erode). TAMPCOL was founded in 1983 by
the government of Tamil Nadu to provide ASU medicaments to Anna Hospital (where it is sited),
and to siddha wards in hospitals and Primary Health Centres located in North Tamil Nadu,
South Tamil Nadu being supplied by the pharmacy of the Government Siddha Medical College
at Palaiyamkottai. The commercial activities of TAMPCOL began in 1985.
66 Curaṇam (Sanskrit: cūṛṇa) is a powder of dry plants, centūram (Sanskrit: (rasa) sindūra) is a
red powder resulting from the calcination of metals or mercury and mercurial salts preparations,
parpam (Sanskrit: bhasman) meaning “ashes”, is a calcinated preparation based on mineral and/
or metallic components mixed with plants, and tirikaṭu curaṇam (Sanskrit: trikaṭucūrṇa) and
tiripala curaṇam (Sanskrit: triphalacūṛṇa) are powders composed of equal parts of three ingre-
dients: the former of pepper, long pepper and dried ginger, and the latter of emblic, chebulic and
belleric myrobalans (Phyllanthus emblica L.; Terminalia chebula Retz.; Terminalia bellirica
(Gaertn.) Roxb.). These two products are used for treating various diseases and are added to
many other drugs. Ayurveda and siddha have, however, some classes of medicaments that are
specific to their formularies such as ariṣṭa (alcoholic herb-based preparation) in ayurveda, and
cuṇṇam (preparation based on the calcification of metals) in siddha.
67 However, I have never noticed siddha practitioners providing their patients with the ayur-
vedic alcoholic liquid called ariṣṭa.
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frontiers of Tamil Nadu, and even of India. At the national level, siddha drugs are
mostly distributed in the neighbouring states of Tamil Nadu, Kerala, Karnataka
and Andhra Pradesh, and in some major cities. The sale of medicines is conducted
mainly by visiting siddha and ayurveda clinics, bio-pharmacies, and nāṭṭu mar-
untu kaṭai (“store of country medicines”), which specialise in raw materials that
practitioners and individuals buy for medical and ritual purposes (homa). Some
siddha practitioners who belong to the traditional milieu and prepare their own
medicines as a part of their practice – a significant difference from siddha doctors
trained in colleges where medicinal preparation is poorly taught – are also
approached by pharmaceutical representatives. In regions such as the southern
districts of Tamil Nadu, where there exists a significant community of traditional
siddha practitioners, the development of manufactured siddha products has been
limited, as patients have more confidence in traditional practitioners and their
renowned family remedies than in university- or college-trained siddha practi-
tioners and the industrialised products they prescribe.68 However, even these
traditional practitioners quite often have to complement their own remedies
with some manufactured ones as they are increasingly consulted for new diseases
for which they have no family remedies.69 In brief, siddha medicines manufac-
tured by private companies are distributed through siddha practitioners via repre-
sentatives and through some shops which generally belong to the financially
strong companies. Those manufactured by the government are delivered to gov-
ernmental hospitals and primary health centres. Patients can buy products not
available at the hospital pharmacy from siddha medical shops, notably IMPCOPS,
situated in the vicinity of the hospitals.
The export market for siddha medicines is limited to a few Asian (Sri Lanka,
Singapore, Malaysia, Japan) and Gulf countries, though there are significant
Tamil communities from India and Sri Lanka in the United States, Canada,
Europe and Australia. The recourse to the internet for buying medicines being
on the increase, some siddha medicines do enter western countries.
Manufacturers have created sites or rent space on commercial sites that specia-
lise in traditional or alternative medicine. When siddha products are intended
for the western market, they are labelled “herbal products” or “dietary supple-
ments” in order to fit in with the authorized nomenclature. Exported products
include cosmetics (capillary oils against alopecia, dandruff and whitening of
68 Sébastia 2012, 2015.
69 Traditional practitioners who have a large clientele receive more than ten sales representa-
tives a week. They buy medicines mostly for treating metabolic disorders and their associated
diseases, cholesterol, hypertension, etc., as well as medicines whose galenic form (capsules,
syrup and tablet) favours their intake by the patient (Sébastia 2015).
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hair, dental powders), dietary powders for boosting appetite or immunity or for
facilitating hepatic functions or memory, and various oils for treating allergies.
By contrast, products for treating disorders such as skin disease, headache, joint
and body pains, arthritis or ulcers, which are quite often based on metallic and
mineral materials, are much less represented on the internet.
Manufacturers do not always differentiate between products to be sold in India
or abroad. K.K. Pharmaceuticals is a small unit of siddha medicines primarily
destined for a private clientele. Its owner, a traditional practitioner from a family
that specialises in varmakkalai70 from the Nagerkoil district has created an institute
for developing the knowledge of varmaṅkaḷ. Via his website, he offers correspon-
dence diploma courses in varmaṅkaḷ and siddha medicine, his booklets and a
quarterly journal, as well as siddha medicines. The latter are not listed on the site
but are obtainable by clients who contact him. He claims to have inherited his
formulas from his maternal uncle. Many of them are made from mercury to which
he attributes high potency. Having no license to export medicines, he slips them
inside booklets or advertisements that he sends by courier. The export of siddha
products by Dr. JRK’s Siddha Research and Pharmaceuticals is, conversely, entirely
legal. However, the labelling of its medicines underlines certain limitations of the
legislation of GMP. For example, its medicinal packages for treating skin diseases
such as vitiligo, eczema or psoriasis, contain an oil for external application and a
box of capsules made of a mixture of plants and iliṅkam centūram (calcination of
purified cinnabar.) The “overseas” order form on the company’s website lists all
the plants under their Tamil and botanical names, but iliṅkam centūram is not
translated so that only informed people are able to identify that it is cinnabar
(mercury sulphide). This labelling conforms to the GMP as there is no obligation to
translate the vernacular terms of non-herbal ingredients. In this way, some man-
ufacturers may challenge the prohibitions which restrict exportation.
4 Suitcase export: a blooming market
for traditional medicines
While western countries seek to protect themselves from contaminated herbal
products exported by Indian companies, they are powerless to regulate informal
70 Varmakkalai is the art (kalai) of varmaṅkaḷ or energy points of the body. It is composed of
two antinomical arts: varmaṅkaḷ, treating a disorder by pressure on, and massage of, the points,
and the martial art which aims to counteract the enemy by injuring the varmaṅkaḷ. See http://
varmam.com (retrieved 20.06.2014) and also Roman Sieler (2015) who has recently conducted
his thesis on this speciality.
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export. The poisoning by drugs purchased directly in the country of production
is considered significant and growing. For example, a report on twelve cases of
poisoning linked to lead contained in ayurvedic products, diagnosed between
2000 and 2003 in five U.S. states, states that the medicaments were bought from
a practitioner in India and that the patients were natives of India (MMWR 2004).
The report points out that the increase in travel abroad, especially in Asian
countries, and the pervasiveness of self-medication, favour the risk of poisoning.
While the focus of this report was on lead intoxication from ayurvedic medicines
bought in India, the increase of mercury poisoning is also a concern, as some
Indian medical studies have shown.71
The increased purchasing of drugs during visits to India is seen by western
countries as a cause of worry. This form of export is called “suitcase export.” Its
volume is not quantifiable, but it is considered a public health issue, as medical
tourism is blooming and Indian diasporic communities increasingly circulate
between their host and native countries. People who turn to siddha practitioners
are mainly Tamils established in the Gulf and in western countries. They benefit
from their stay in India to buy medicines unobtainable in their host countries,
to consult a practitioner or to stay in one of the few pleasantly appointed
siddha hospitals.72 In the Kanniyakumari district where I conducted a large
part of my fieldwork, because there is a great tradition of siddha medicine and
varmakkalai, I frequently met women who visit practitioners to buy drugs for
their husbands working abroad, especially in Gulf countries. The drugs, bought
in large quantities, are sent to their husbands through a peer who is on vacation.
This is a way for Tamil migrants to continue their treatment started in
India, especially to treat chronic disorders such as body pain, digestive distur-
bances or blood pressure. Sjaak van der Geest and colleagues (1996) emphasize
that migrants are extremely motivated to get the drugs from their native
country because the drugs constitute a cultural component with which they
can identify. It is, indeed, not uncommon for Tamil migrants who never used
siddha medicine before to turn to it when they visit India. They consult either a
siddha practitioner recommended by their neighbours, or one of those who tout
the benefits of their drugs on Tamil TV channels broadcast abroad or in
71 Dasgupta/Mammett-Stabler 2011; Gogtay et al. 2002.
72 This point is extremely important as self-medication is very common both in India and
Western countries and is certainly the main cause of poisoning by traditional medicines due to
the accumulation of heavy metals in organs. Surprisingly, articles on intoxication by heavy
metals rarely pinpoint self-medication; this is a lacuna particularly in the articles of Saper et al.
(2004, 2008). On the matter of self-medication, see Trisha Greenhalgh (1987), Sjaak van der
Geest (1987), Sjaak van der Geest et al. (1996), and Kamat/Nichter (1998).
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Tamil magazines and newspapers distributed in host countries. These often use
the iconic figures of Akattiyar, Tirumular or Hanuman to attract a clientele.73
Foreigners, more familiar with ayurvedic medicine, rarely approach a cittamar-
uttuvar, but when they do, it is often to find a cure for a debilitating disease for
which they get no improvement from biomedicine or ayurveda. They usually
take the address of a siddha practitioner from a Tamil friend and quite often
consult with an interpreter, as siddha practitioners are rarely proficient in the
English language. The language barrier also constitutes an obstacle to making
siddha medicine better known.
According to my observations of more than twenty siddha practitioners of
the Kanniyakumari district, Siddha practitioners rarely prescribe metal-based
drugs for foreign clients. The drugs they provide may have been inherited from a
family practice, but re-adapted to the clientele by replacing metal with plants
considered to be of similar efficacy. This adaptation is based on the fact that, on
the one hand, they do not want to incur the risk of poisoning their patients and
tarnishing their reputation, and on the other hand, the idea that foreigners are
attracted by herbal medicines. In the last decades, siddha medicines have
received growing interest from the public. However, according to my observation
of consultations by some traditional practitioners over five years, this trend does
not mean that patients are fully confident in the efficacy of siddha medicines.
Practitioners point out that it is difficult to attract new customers while it is
much easier to lose them if a problem occurs. To protect their reputation as
individual practitioners as well as the public perception of the efficacy of their
medicines, some siddha practitioners, such as Sivabalan who runs a forty-bed
hospital in Kanniyakumari district, refuse to treat patients with severe health
conditions (heart problems, renal failure, etc). Sivabalan’s prudence is not a
marginal phenomenon as practitioners are frequently consulted when biomedi-
cine has failed or to avoid surgery (Sébastia 2015). To protect their reputation,
siddha practitioners often only provide metal-based medicines when they deem
them indispensable. Jeyananda, a practitioner who run an eighty-bed hospital in
Kanniyakumari district, confided in me during one of my numerous stays
between 2006–2011:
73 In the context of siddha medicine, Hanuman is considered to have brought the cañcīvi
panacea into Tamil Nadu, when a fragment of the Himalayas that he was carrying to Sri Lanka
to revive Rama, fell. Cañcīvi is a kind of mythical herb, the plant varying according to the
practitioner. In the Nagerkovil district, a hill close to Kanniyakumari is considered a fragment of
the Himalaya transported by Hanuman. It is called Maruntuvālmalai (mountain of the medicinal
plants) and has at its summit a small temple dedicated to Hanuman (Parthipan/Santhanakumar
2005).
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I do not prepare medicines with metals. My father and grandfather used metals but not me.
This is a big issue now since there have been problems of intoxication in America. And the
Indian government is very conscious of this. If a patient complains that he has had
problems with our medicines, the government will immediately come and cause us
problems. Only for exceptional cases, I give this kind of medicines, but they come from
a company that I know well; I visited it before buying the medicines.
In fact, practitioners like Jeyananda, Sivabalan or members of the Madurai
Siddha Sangham are well informed about the sanitary alert from foreign coun-
tries and the risks related to metal-based medicines. Even though their practice
does not oblige them to follow the rules made for pharmaceutical marketing,
they are afraid of being accused of quackery if a patient develops adverse
effects. Recurrent articles in the press about governmental interventions, closing
clinics and imprisoning owners accused of quackery, contribute to the precau-
tions taken by certain practitioners, notably those who run a hospital or have an
extensive clientele.
5 Controversy over metal-based drugs: a question
of knowledge
Siddha practitioners claim that the preparations based on metal, and in parti-
cular on mercury and mercurial complexes, have higher curative properties
than herbal products. They argue that siddha medicine is more efficient than
ayurveda because of the prestigious cittarkaḷ’s expert knowledge of mercury.
However, members of the Madurai Siddha Sangham emphasise that metal-
based remedies must be prescribed as a last resort: “We give first herbal
medicines. Only if the condition of the patient does not improve or becomes
severe, we give medicines with mercury or metals, but for a few days only, not
more than two weeks.”74 They argue that this restriction on the utilization of
metallic components in therapy is mentioned in an unreferenced second-hand
book entitled Citta maruttuvaṅka curukkam by Cannigaiper Subramaniya
Uthamaroyan. Justifying changes in medicines by tradition is a way to legit-
imise new forms of therapy and to free siddha medicine from its reputation of
an alchemical science, i.e. obscure, magical and dangerous. It is however
74 Statement made during an open discussion with six members of the Madurai Siddha
Sangham in 2007 and confirmed by several practitioners in a recent meeting.
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important to underline that the cittarkaḷ were extremely aware of the risk of
poisoning by mercury, arsenic and some plants.75 The report of the Usman
committee states:
In the hands of the experts of this system (siddha), the cases of ‘mercurialism, arsenic
poisoning, etc. are as rare as they are common in the hands of these quacks. It is for this
reason that some Ayurvedists (specially of the Malabar School) prefer to confine them-
selves solely to the use of the vegetable remedies (…) It is also likely that the idea prevalent
among some Ayurvedists that, as a rule, recourse must first be had to vegetable remedies,
and it is only when they fail or the disease has progressed too far, that Siddha treatment
should be undertaken, has its origin in the belief that the potency of the Siddha remedies
for good is as great in the hands of its experts, as their potency for evil, in the hands of the
quacks.76
Siddha practitioners subject their iatrochemical products to long and
repeated processes (grinding, pounding, calcinations) aimed at improving the
efficacy of their drugs and minimizing the iatrogenic effects. Mercury and
mercurial components as well as other poisons (plants and metals) are always
used after a long process of purification (cutti) for neutralising the poisonous
substances. The purification process varies according to the raw material.
Cinnabar (ilaṅkam) is detoxified by being soaked in lemon juice for one day
(Figures 10–12) or in mother’s milk for ten days, while mercury (iracam) is
detoxified by grinding it with a combination of turmeric, coconut ash and
Figure 10: Soaking in
lemon juice.
75 See Anandan 1999.
76 Usman 1923: 87.
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spider’s web for twenty-four hours, and then, after washing, by being boiled in a
plant juice and washed again77 (Figure 13). Once detoxified, these products
are ground with various ingredients (Figure 14) and calcinated at a temperature
regulated by the quantity of cow-dung (Figure 15 and Figures 16–18).
Figures 10–12: Process of detoxification of iliṅkam (cinnabar): Photos taken at the Government
Siddha Medical College GSMC, Palayamkottai ©Christian Sébastia.
Figure 12: Soaking and
boiling plant juice.
77 As a comparison with processes of purification in ayurvedic alchemy, one may consult the
volume I of Mookerji (2006). Some ingredients are similar but their combination is different.
Figure 11: Washing and
drying.
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Siddha practitioners also developed antidotes for neutralizing iatrogenic effects.
According to the Nañcu murivu nūl (a book of antidotes for poisons), cinnabar
poisoning is treated for forty days with a decoction of nutmeg, pepper, root bark
of Gossypium arboreum and sugar; calomel (pūram) poisoning is treated with a
Figure 13: Purification of iracam. Photo taken at the Government Siddha Medical College GSMC,
Palayamkottai ©Christian Sébastia.
Figure 14: Mechanisation of the long processing procedure, iracam-based formulation. Photo
taken at the Government Siddha Medical College GSMC, Palayamkottai ©Christian Sébastia.
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decoction of different parts of four plants called nilappanai kilaṅku kuṭinīr taken
for two to three weeks.78
Even though siddha practitioners seem to have preserved their iatrochemical
know-how much more than their ayurvedic peers, their tendency to avoid metals,
and particularly mercury, in their medicaments may ultimately lead to the decline
Figure 15: Calcination of iliṅkam centūram. Photo taken at the Government Siddha Medical
College GSMC, Palayamkottai ©Christian Sébastia.
Figure 16: Putting the
kasturi karuppu after
into a cloth ©Christian
Sébastia.
78 The signs and symptoms of cinnabar poisoning described in this text are: ulceration of the
digestive system from larynx to intestine; dysphasia and aphasia; bad breath; reluctance to
pungent taste; and saliva like spoiled toddy or vinegar (Anandan 1999: 31).
Preserving Identity or Promoting Safety? 961
of siddha knowledge and identity. Through the strict use of plants, siddha
medicine hardly differs from ayurvedic medicine as it is practised in the neigh-
bouring state of Kerala. Siddha practitioners refer to Kerala ayurveda when they
try to convince patients of the therapeutic effects of plants. Their goal is to make
their medicine as attractive as the plant-based ayurveda practised in Kerala,
which is perceived by both Indian and foreign clientele as the authentic ayurveda.
However, not all siddha practitioners share the same view in regard to the
equivalence of efficacy between plants and metals. Several practitioners I visited
were proud to exhibit their iatrochemical products such as solidified mercury
Figure 17: Preparing the
calcinations of kasturi
karuppu (method of
obtaining a moderate
temperature).
Figures 16–18: Process of calcination for kasturi karuppu (including iracam, pūram, iliṅkam).
Photos taken at the Government Siddha Medical College GSMC, Palayamkottai ©Christian
Sébastia.
Figure 18: Collecting
the kasturi karuppu
after calcination and
cooling – the product
will be powdered and
stored.
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(iracamaṇi), muppū or kaṭṭu as a testimony of their skills in siddha medicine.79 A
few claim that they have discovered methods of purifying metals, formulas and
processes of making complex medicaments thanks to rigorous asceticism. They
assert that they are not afraid of causing poisoning because they strictly follow
the instructions given in the cittarkaḷ’s texts, inherited from their ancestors or
gurus, or revealed during meditation. Their opinion of practitioners who have
abandoned the use of metals is severe. They accuse them of being mediocre
practitioners, in quest of money rather than being concerned with their patients’
health. They interpret their refusal to use metals as a pretext to hide their
ignorance and lack of expertise. Some siddha practitioners insist that, even
though the process costs a lot, it is necessary to redo calcination until the colour
and aspect of the final product are perfect, in order to ensure the safety and
quality of the preparation.80 To quote Egilane, a practitioner who acquired his
practice of yoga and knowledge of siddha from a twenty-year apprenticeship to
his guru who had founded a kurukulam (traditional school of teaching from
master “guru” to disciple “śiṣya”):
Those who do not want to use metals are poor practitioners. When you know how to treat
metals correctly, carefully respecting each stage of fabrication until the final product, you
are not afraid to give drugs based on metals. Practising siddha medicine is difficult
because it requires time, patience, trust and a long practice of yoga. It is only through
yoga that we can understand the cittarkaḷ’s formulas and know the secrets of purifying and
transforming the metals. But how many practitioners today practise yoga? So many
practitioners prefer to give herbal medicines; they are so easy and cheap to prepare. But,
this is not siddha medicine these people practise, it is ayurveda.81
In Egilane’s opinion, the difference between the practice of ayurvedic and
siddha medicines is that the former is primarily commercial while the latter
must not generate financial profit because the knowledge is intrinsically linked
to esoteric values. As I have noticed in my extensive fieldwork, the siddha
79 Sébastia 2015.
80 Siddha practitioners consider calcination an important part of the purification process.
While I observed that Egilane, among others, did not hesitate to redo the calcination process
if his final products were not satisfying, in governmental pharmacy at the siddha college of
Palaiyamkottai, I noticed sometimes that the purification and calcination processes were not
complete.
81 Interview conducted in May 2009 at Egilane’s home at Pondicherry. According to Egilane,
the practice of yoga is key to the fabrication of medicinal preparations: “Yoga is the path of
excellence to develop the knowledge of siddha medicine through its practice; the ascetic can
reveal the location of the necessary herbs for the preparation of remedies, and the method of
purifying a metal or creating a new formula.”
Preserving Identity or Promoting Safety? 963
practitioners who point to this difference belong mainly to the category of
traditionally trained practitioners. For example, during a discussion in
February 2008 with members of the Madurai Siddha Sangham, one practitioner
argued: “Our medicine is powerful because of the great knowledge of our cittar
who developed alchemy. But nowadays, we have to be careful because if we use
medicine with metals, we are accused of quackery. To avoid to be bothered by
the government, we prefer to give plants to the patients, like ayurvedic people”.
As I have observed during my interaction with the institutionalised practitioners
working in siddha colleges and at CRIS (Council Research Institute for Siddha),
the term quack is frequently used as a synonym for traditional siddha practi-
tioners: “90% of traditional siddha practitioners are quacks. They have no
education, but they claim to know secrets from their gurus and ancestors and,
using astrology and mantra, they cheat people.”82 Admittedly, there are still self-
confident traditional practitioners who continue to treat patients with metal-
based medicines (Sébastia 2010, 2015), and to conduct research on siddha
manuscripts and texts in order to discover iatrochemical recipes for treating
difficult curable diseases. However, the fact that siddha medicine has been
institutionalised in reflection of biomedical sciences, asceticism and esotericism
which contribute to siddha knowledge and medical practice tend to disappear,
reducing this system to the sole practice of medicine. As Rajendran, a practi-
tioner of Kanniyakumari district who runs a sixty-bed hospital, told me when I
questioned him about his practice compared to that of his father: “Since my
childhood, I learnt siddha from my father and from ācāṅkaḷ. From the ācāṅkaḷ, I
learnt alchemy and secret formulas of our great cittar. My father was an expert in
medicine and he was also mantiravāṭi (magician, sorcerer). But I do not practise
mantirakkaḷ because patients come to us only for medicines. Mantiraṅkaḷ were
efficacious, they worked well in psychological issues, but practising them will
give us the reputation of quack.”83 Interestingly, while Rajendran relates magic
to quackery, he feels that his training in alchemy has been the key to developing
his “powerful” medicines. In contrast to Jeyananda, he does not fear being
accused of quackery if his metal-based medicines cause iatrogenic effects. His
trust in his medicines is such that, for four years, he has been producing them
on a large scale and selling them on the market. In a certain way, Rajendran
confirms Egilane’s statement regarding the relation between confidence in
metal-based medicines and the skill to produce them.
82 Interview at the CRIS, Chennai, in December 2006.
83 Interview in Rajendran’s hospital in May 2008.
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6 Conclusion
The use of metals and the complexity of medicinal preparations are still testi-
monies of a past dominated by discoveries about matter and by philosophical
and spiritual ideologies. However, the question arises how long this rich knowl-
edge will survive in the face of modern considerations about safety and efficacy
and the newly imposed accompanying legislation. Indeed, acting on the
demands of pharmaceutical and biomedical lobbies, western countries implicitly
force the governments of the countries of origin of the traditional medicines to
adopt their regulations on drugs in matters of safety, standardisation, clinical
trials, etc. (WHO, 2002). This hegemonic attitude is worth enquiring into. The
health warning from Saper and his colleagues begs more questions. Why is the
number of poisoning by heavy metals in ayurvedic and related medicines
reported in medical literature so small if the medicines themselves are suppo-
sedly so toxic? This question is all the more relevant in the case of mercury as
there are hardly any medical articles which warn of poisoning by mercury and
mercurial components from HMPs (personal communication, October 2006).
Lastly, why have no supplementary studies been conducted to analyse the
bioavailability of heavy metals in the organism? If traditional medicines, as
the World Health Organization suggests,84 have the potential to heal various
diseases biomedicine is unable to cure, is there then no risk that such health
warnings may prevent patients from improving their conditions?
A first version of this study, funded over two years by the French Institute of
Pondicherrry, was published in 2011 under the title “Le passage des frontières de
médecines pas très douces: prévenir l’innocuité ou préserver l’authenticité? Le
problème des formulations iatrochimiques dans la médication siddha” in the
Revue de l’anthropologie des connaissances 5.1: 71–98. The present paper has
been updated and enlarged with information on the Tamil siddha tradition
linked with tantrism and alchemy with a special focus on mercury. It has greatly
benefited from comments by Dagmar and Dominik Wujastyk, especially about
the history of ayurvedic alchemy, as well as comments of the two reviewers.
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